ArticleGastro hep advances2022

Phase II Feasibility Study of the Efficacy, Tolerability, and Impact on the Gut Microbiome of a Low-Residue (Fiber) Diet in Adult Patients With Mitochondrial Disease.

David Houghton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.